Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Consumers want more from wearables market

November 6, 2014 Medical Communications, Sales and Marketing Apple, Microsoft, Samsung, mhealth, pwC, watch, werables

The interest in mobile health (mHealth) wearables is gaining traction, but consumers want more affordable devices that offer greater engagement …
News

Roche unveils plans for first Asian diagnostics plant

November 6, 2014 Medical Communications, Sales and Marketing Asia-Pacific, China, Roche, asia pacific, asian, manufacturing

Roche has said it will invest 450 million Swiss francs ($468m) in the construction of a diagnostics manufacturing facility in …
News

ROCK medical communications appoints MD

November 6, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston, ROCK, terence bradley

ROCK medical communications has appointed Terence Bradley to be its managing director. Most recently Bradley was the founding director of …
Appointment

Former Vodaphone head to lead ABPI comms

November 5, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aileen Thompson, meadon, vodaphone

The ABPI has appointed a new director of communications in Aileen Thompson, a former Vodaphone head who replaces Catherine Meadon in …
Appointment

Wales Assembly facing questions over cancer

November 5, 2014 Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology

The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …
News

Retrospective study backs Iressa use in oesophageal cancer

November 5, 2014 Research and Development, Sales and Marketing AstraZeneca, Cancer, Cancer Oesophagus Gefitinib, Iressa, gefitinib, oncology

A group of oesophageal cancer patients can increase their survival by six months or more if treated with AstraZeneca’s Iressa, …
News

LabCorp buys Covance for $6.1 billion

November 5, 2014 Research and Development, Sales and Marketing CRO, Covance, king, labcorp, medical

US medical diagnostics firm LabCorp has entered the drug development business via a $6.1 billion deal to buy contract research …
News

Horizon Discovery names executive director

November 5, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Horizon Discovery, david smoller

Cambridge-based genetics research firm Horizon Discovery has appointed Dr David Smoller to be an executive director on its board. Smoller …
Appointment

AstraZeneca buys biotech Definiens

November 4, 2014 Research and Development, Sales and Marketing AstraZeneca, Janssen, MedImmune, Pharmacyclics, binnig, definiens

AstraZeneca has strengthened its oncology capabilities with the acquisition of Definiens, a German company that has pioneered cancer imaging and …
News

Astellas teams up with Proteostasis against protein defects

November 4, 2014 Research and Development, Sales and Marketing Astellas, Biogen IDEC, Protein, Proteostasis, upr

Astellas has announced it will collaborate with Proteostasis Therapeutics to develop drugs for diseases caused by protein defects, using the …
News

Sir Michael Rawlins appointed chair of MHRA

November 4, 2014 Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, NHS, NICE, gordon duff, michael rawlins

The Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed that former NICE head Sir Michael Rawlins is to serve …
News

NICE backs GSK’s leukaemia drug Arzerra following price cut

November 4, 2014 Sales and Marketing Arzerra, CLL, GSK, NHS, NICE, leukaemia

NICE has recommended that GlaxoSmithKline’s Arzerra be prescribed under the NHS for patients with chronic lymphocytic leukaemia (CLL), after a …
News

EMA review for Biogen Idec’s haemophilia A therapy

November 4, 2014 Sales and Marketing Biogen, elocta, eloctate, haemophilia a, idec, sobi

The EMA is set to review Biogen Idec and Sobi’s haemophilia A therapy Elocta after validating the drug’s marketing authorisation …
News

Alnylam poaches VP from Bristol-Myers Squibb

November 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alnylam, pushkal garg

US-based RNAi therapeutics firm Alnylam Pharmaceuticals has appointed Dr Pushkal Garg to the position of senior vice president of its …
Appointment

AstraZeneca completes respiratory deal with Almirall

November 3, 2014 Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory

AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026